After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Inovio Pharmaceuticals, Inc.
Trade-Ideas LLC identified Inovio Pharmaceuticals (INO) as a weak on high relative volume candidate
Cramer loves Popeyes Louisiana Kitchen but he can't recommend Harman International right now.
There's been so much news coverage about whether the United Kingdom will leave the European Union that it's making us numb, Cramer says.
Rising Biotech Company Inovio believes that its simultaneous vaccine efforts are well on their way to approval from the FDA.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.